The evaluation of gene polymorphisms associated with autoinflammatory syndrome in patients with palindromic rheumatism complicated by intermittent hydrarthrosis.
Intermittent hydrarthrosis
MEFV
Palindromic rheumatism
Journal
Clinical rheumatology
ISSN: 1434-9949
Titre abrégé: Clin Rheumatol
Pays: Germany
ID NLM: 8211469
Informations de publication
Date de publication:
Mar 2020
Mar 2020
Historique:
received:
29
05
2019
accepted:
09
12
2019
revised:
12
11
2019
pubmed:
4
1
2020
medline:
6
1
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
Palindromic rheumatism (PR) is a type of acute arthritis or periarthritis characterized by recurrence, paroxysmal, or intermittent disease attacks and occasionally progresses to other types of rheumatic disease. PR patients who are anti-citrullinated protein antibodies (ACPA)-negative have a high prevalence of MEFV gene polymorphisms, and intermittent hydrarthrosis (IH) is also associated with MEFV polymorphisms. The purpose of this study was to evaluate the clinical characteristics of and autoinflammatory syndrome-associated gene polymorphisms in patients with PR and IH and to identify predictive factors for developing other rheumatic diseases. Six PR patients (four females; median age at disease onset, 20.0 years; median age at evaluation, 47.0 years) were retrospectively evaluated for clinical features and polymorphisms in genes responsible for autoinflammatory diseases. All six patients fulfilled the diagnostic criteria for PR and showed clinical feature of IH. Two presented with recurrent fever. All six patients were negative for rheumatoid factor and ACPA and had normal articular X-ray findings. Among the six patients, MEFV gene polymorphisms known to cause FMF were identified in four, CIAS1 mutation was observed in one, and TNFRSFIA mutation was observed in one. Colchicine was effective in three patients with MEFV polymorphisms. The other five patients continued to experience PR, although three patients achieved remission with medication. PR presenting with IH might be associated with gene polymorphisms responsible for autoinflammatory diseases; colchicine appears to be effective in these patients.Key Point• Palindromic rheumatism with intermittent hydrarthrosis might be associated with gene polymorphisms responsible for autoinflammatory diseases.
Identifiants
pubmed: 31897954
doi: 10.1007/s10067-019-04883-w
pii: 10.1007/s10067-019-04883-w
doi:
Substances chimiques
Anti-Inflammatory Agents, Non-Steroidal
0
MEFV protein, human
0
Pyrin
0
Colchicine
SML2Y3J35T
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
841-845Références
Br Med J. 1957 Jan 19;1(5011):139-43
pubmed: 13383213
Ann Rheum Dis. 2013 Jan;72(1):155
pubmed: 22887853
Ann Rheum Dis. 2015 Apr;74(4):635-41
pubmed: 25628446
J Rheumatol. 2014 Aug;41(8):1650-5
pubmed: 25028368
Nihon Rinsho Meneki Gakkai Kaishi. 2011;34(5):355-60
pubmed: 22041422
J Rheumatol. 1999 Mar;26(3):540-5
pubmed: 10090159
Am J Med. 1992 Oct;93(4):451-60
pubmed: 1341421
Arthritis Rheum. 2007 Aug;56(8):2784-8
pubmed: 17665427
Arthritis Rheum. 2006 Jul;54(7):2334-5
pubmed: 16802374
Medicine (Baltimore). 2014 May;93(3):158-64
pubmed: 24797171
Arthritis Res Ther. 2014 Sep 27;16(5):439
pubmed: 25261100
Medicine (Baltimore). 2012 Nov;91(6):337-43
pubmed: 23111802
Calif Med. 1949 Nov;71(5):359-61
pubmed: 15390577
Scand J Rheumatol. 1987;16(6):413-20
pubmed: 3423751
Rheumatology (Oxford). 2003 Feb;42(2):391-2
pubmed: 12595650
Nat Immunol. 2013 May;14(5):454-60
pubmed: 23502856
Arthritis Rheum. 1997 Oct;40(10):1879-85
pubmed: 9336425